Effect of Immunosuppressive Diseases and Rituximab Infusions on Allowing COVID-19 Infection to Relapse | The Permanente Journal
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial - The Lancet
PV | RITUXAN® (rituximab) Safety Data
Both the rituximab dose and maintenance immunosuppression in steroid-dependent/frequently-relapsing nephrotic syndrome have important effects on outcomes - ScienceDirect
GPA & MPA | RITUXAN® (rituximab) Safety on Follow Up Treatment
Use of rituximab in paediatric nephrology | Archives of Disease in Childhood
Rituximab in the treatment of skin diseases Rajagopalan M, Vasani R - Indian J Drugs Dermatol
Frequency of Rituximab related side effects. | Download Table
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
immediate and long-term side effects of rituximab administration | Download Table
Rituximab in MS | Experimental MS Treatments | Multiple Sclerosis News Today
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group - ScienceDirect
immediate and long-term side effects of rituximab administration | Download Table
Rituximab (Rituxan) Drug Information
Rituxan Side Effects - HRF
Frontiers | Rituximab Therapy for Primary Sjögren's Syndrome
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
RA | Safety Data & Possible Side Effects | RITUXAN® (rituximab)
Cutaneous Adverse Effects of Surface-Targeted Monoclonal Antibodies – Consult QD
Rituximab-induced lung disease: a systematic literature review | European Respiratory Society
The importance of continuing with RITUXAN® (rituximab) for RA Patients
effects of rituximab in the patient described in this case report... | Download Scientific Diagram
Frontiers | Past, Present, and Future of Rituximab—The World's First Oncology Monoclonal Antibody Therapy
Side Effects of Rituximab for Cold Agglutinin Disease (CAD)
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial - The Lancet Neurology
RA | RITUXAN® (rituximab) Proposed Mechanism of Action (MoA) in Rheumatoid Arthritis
GVHD in pediatric HSCT patients: Clinical trials for Rituximab - Oncology Nurse Advisor
Rituximab - Wikipedia
